Kamala Harris

Joe Biden

Dean Phillips

Marianne Williamson

Donald Trump

Vivek Ramaswamy

Nikki Haley

Ron DeSantis

Cornel West

Robert F. Kennedy

2024 United States Presidential Election

Novavax Inc. shares fell as much as 24% after US regulators placed a hold on the company’s experimental influenza and Covid-19 combination vaccines because a study volunteer developed a serious nerve disorder.

Live Mint

New Delhi

Delhi Division

Delhi

India

Novavax Plunges After FDA Hold on Flu, Covid Vaccine Work

The so-called clinical hold is due to a single report of nerve damage in a patient who received the combination shot in a phase two trial.

Ad Fontes Media

All Sides

Media Bias/Fact Check

CNBC

Roberts family

United States

Novavax says FDA put hold on combination Covid-flu shot and influenza vaccine; shares plunge

HT Media

Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its COVID-19-and-flu combination and stand-alone flu vaccine candidates, following a case of motor neuropathy in a participant in a mid-stage trial.

MarketWatch

Murdoch family

Novavax’s stock slides 16% after FDA puts clinical hold on COVID and flu vaccine candidates

FDA pauses Novavax's flu-COVID vaccine trial, stock sinks 20% Yahoo Finance
Novavax Says FDA Puts Clinical Hold on Covid-19, Flu Vaccines The Wall Street Journal
Novavax Stock Tumbles 20% After FDA Pauses Clinical Trial On Security Concerns Barron's
US FDA pauses Novavax's trial of combo COVID-flu…

BizToc

FDA pauses Novavax's flu-COVID vaccine trial, stock sinks 20%

A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images    
Novavax on Wednesday said the Food and Drug Administration has put a hold on its application for a combination shot targeting Covid and influenza and a stand-alone flu vaccine, sending the company’s shares down sharply.  The …

Stockxpo - A professional network of traders, investors and analysts

Novavax’s post-Covid path ran into a speed bump Wednesday, as the company announced a clinical hold on its Covid-influenza combination vaccine and its standalone flu shot ...

Endpoints News

FDA places hold on Novavax's Covid-flu and standalone influenza vaccines

Novavax Inc. shares dropped as much as 24% after U.S. regulators announced a hold on the company's experimental combination vaccines for influenza and COVID-19. This decision follows a report of a serious nerve disorder affecting one of the study volunteers.

market-news24.com

Novavax Shares Plunge 24% After Vaccine Study Halt Due to Safety Concern - Market-News24

The hold, which was made in response to a serious adverse event report, could impact the company’s plans to start a Phase 3 trial of a combination shot for COVID-19 and influenza.

biopharmadive.com

FDA puts Novavax flu vaccine trials on hold

The U.S. Food and Drug Administration has put Novavax’s (NASDAQ: NVAX) trial of an experimental COVID-flu vaccine combination on hold after one person who received the shot reported nerve damage, the company said on Wednesday. Shares of the vaccine maker plunged about 20% to $10.13 in early trading. Novavax said it was working with the FDA to resolve the clinical hold on the trial of its combination shot and the standalone flu vaccine. A partici…

abbonews.com

Novavax (NASDAQ: NVAX) Stock Tumbles After FDA Pauses COVID-Flu Vaccine Trial

The U.S. Food and Drug Administration (FDA) have halted trials for Novavax’s experimental COVID-19-flu combination vaccine and its standalone flu shot after a trial participant reported nerve damage. The participant, who received the COVID-flu vaccine during a Phase 2 trial in January 2023, later developed motor neuropathy — a condition that affects the nerves controlling muscles. Novavax said it was only informed of the case last month. In resp…

National Daily Newspaper

Novavax COVID-Flu vaccine trial suspended after participant reports nerve damage

Novavax Plunges After FDA Hold on Flu, Covid Vaccine Work

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics